Company record
Acerta Pharma B.V.
- B.V.
Signals
1 on record
- EPO patentsPatent
Patent publication FI3179991T4 by Acerta Pharma B.V.: THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR AND A BCL-2 INHIBITOR.
EPO patentsRelevance21
Watch · 80% confidence
Loading company…
Company record
1 on record
Patent publication FI3179991T4 by Acerta Pharma B.V.: THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR AND A BCL-2 INHIBITOR.
EPO patentsRelevance21
Watch · 80% confidence